In this episode, Dr. Monika Lamba, a pathologist from Q Solutions, discusses the transformative role of digital pathology in clinical trials. Despite its origins aiming to streamline trials, it's not yet the default. Dr. Lamba explores its evolution from

In this episode Dr. Monika Lamba Saini and Bruno Larvol of LARVOL & Friends discuss the role of artificial intelligence (AI) in pathology and its potential impact on healthcare.They delve into the slower adoption of AI in pathology compared to other me

In this episode, Megan McCausland, Scientific Advisor for Flow Cytometry at Q2 Solutions, and Scott Bornheimer, Associate Director of Medical and Scientific Affairs at BD Biosciences talk about the possibilities of flow cytometry as a companion diagnostic

With fewer people covering more roles with less specialization and novel therapeutics with unique testing requirements, the needs of small biotech companies in clinical trials are different from large

In this episode, Alex Watt, Global Head for Biotech Integrated Laboratory Solutions and Alan Wookey, Global Head of Companion Diagnostics discuss how to manage both scientific and operational risk in

Alex Watt is the Global Head for Biotech Integrated Laboratory Solutions at Q2 Solutions. In this episode, the first of a three-part series, he talks about how biotech companies can best prepare for t

Becoming bilingual in bioanalysisIn this podcast Barry Jones (Director, LCMS Biologics and Biomarkers at Q Solutions) and Adriane Spytko (Manager, LCMS Biologics at Q Solutions; both NY, USA) discuss hybrid assays using both LBA and LCMS techniques.

Most clinical trials involve a variety of laboratory vendors and CROs to provide services during the course of the study. Disparity in how each vendor handles, tracks and reports its data can present

Taking an assay from bench to an automated platformIn this podcast, Prakash Bhosale (Director of Discovery ADME at Q2 Solutions; IN, USA) discusses high-throughput in vitro screening and how to under

In this podcast interview, Jason Evans (Scientist at Q Solutions) discusses the importance of automation and key advantages of taking an assay from the bench to an automated platform. He also explains the increase in throughput when his lab transitioned